Quarterly Activities Report and Appendix 4C

Jul 30, 2026 at 6:29 PM EDT · Issued by Percheron Therapeutics Limited via ASX

Filed with ASX · Jul 30, 2026 at 6:29 PM EDT

On 6ix: 6ix.com/news/quarterly-activities-report-and-appendix-4c-139

ASX Announcement Percheron Therapeutics Limited ABN 41 095 060 745 ASX: PER | FSE: AWY | US OTC: ATHJY QUARTERLY ACTIVITIES REPORT AND APPENDIX 4C Melbourne, Australia – 31 July 2026: Percheron Therapeutics Limited (ASX: PER) (‘the Company’), an international...

View Attachment

6ix hasn’t read this filing yet.

Percheron Therapeutics Limited on 6ix

Story so far

Quarterly Activities/Appendix 4C Cash Flow ReportJan 30, 2026
Appendix 4E and Annual ReportAug 28, 2025

Earlier from Percheron Therapeutics

Results of Entitlement OfferApr 14
Prospectus - Non-renounceable Entitlement OfferMar 15
Non-renounceable Entitlement OfferMar 15
Half Yearly Report and AccountsFeb 26
Quarterly Activities/Appendix 4C Cash Flow ReportJan 29

Later from Percheron Therapeutics

Percheron Therapeutics Announces CEO SuccessionAug 9
Notice of date of AGM and other relevant datesAug 11
Application for quotation of securities - PERAug 14
Appendix 4E and Annual ReportAug 18
Appendix 4G and Corporate Governance StatementAug 18

All Percheron Therapeutics news releases

Follow Percheron Therapeutics into a list and get an email when it puts out news.

Follow Percheron Therapeutics